Application of ⁸⁹Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody.

Autor: Stergiou, N., Wuensche, T. E., Schreurs, M., Mes, I., Verlaan, M., Kooijman, E. J. M., Windhorst, A. D., Helboe, L., Vergo, S., Christensen, S., Asuni, A. A., Jensen, A., Van Dongen, G. A. M. S., Bang-Andersen, B., Vugts, D. J., Beaino, W.

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging; Apr2023, Vol. 50 Issue 5, p1306-1317, 12p, 3 Diagrams, 1 Chart, 3 Graphs

Corrigendum to 'SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake' [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31] (Nuclear Medicine and Biology (2021) 96–97(S) (S1–S114), (S0969805121X00042))

Autor: Stergiou, N., Wünsche, E. T., Mes, I., Schreurs, M., Verlaan, M., Kooijman, E. J. M., Windhorst, A. D., Dongen, G. A. M. S., Helboe, L., Vergo, S., Christensen, S., Asuni, A., Jensen, A., Bang-Andersen, B., Vugts, D. J., Beaino, W.

Publikováno v: Nuclear Medicine and Biology. Elsevier Inc.
Stergiou, N, Wünsche, E T, Mes, I, Schreurs, M, Verlaan, M, Kooijman, E J M, Windhorst, A D, Dongen, G A M S, Helboe, L, Vergo, S, Christensen, S, Asuni, A, Jensen, A, Bang-Andersen, B, Vugts, D J & Beaino, W 2021, ' Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31] (Nuclear Medicine and Biology (2021) 96–97(S) (S1–S114), (S0969805121X00042)) ', Nuclear Medicine and Biology . https://doi.org/10.1016/j.nucmedbio.2021.05.006

The authors regret . The authors would like to apologise for any inconvenience caused.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::31f8d957822e8ab24d242ee036768a2b
https://research.vumc.nl/en/publications/3f868859-8c02-4470-a3af-8806b2d6ce78

Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31]

Autor: Stergiou, N., Wünsche, E.T., Mes, I., Schreurs, M., Verlaan, M., Kooijman, E.J.M., Windhorst, A.D., Dongen, G.A.M.S., Helboe, L., Vergo, S., Christensen, S., Asuni, A., Jensen, A., Bang-Andersen, B., Vugts, D.J., Beaino, W.

Publikováno v: In Nuclear Medicine and Biology January-February 2022 104-105:65-65

Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond.

Autor: Perdaens, Océane¹ (AUTHOR) oceane.perdaens@uclouvain.be, van Pesch, Vincent^1,2 (AUTHOR) vincent.vanpesch@saintluc.uclouvain.be

Publikováno v: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p12637. 68p.

Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease.

Autor: Holm TL; Global Research, Novo Nordisk A/S, Maaloev, Denmark., Tornehave D; Global Research, Novo Nordisk A/S, Maaloev, Denmark., Søndergaard H; Global Research, Novo Nordisk A/S, Maaloev, Denmark., Kvist PH; Global Research, Novo Nordisk A/S, Maaloev, Denmark., Sondergaard BC; Global Research, Novo Nordisk A/S, Maaloev, Denmark., Hansen L; Global Research, Novo Nordisk A/S, Maaloev, Denmark., Hermit MB; Global Research, Novo Nordisk A/S, Maaloev, Denmark., Holgersen K; Novo Nordisk LIFE In Vivo Pharmacology Centre, Frederiksberg, Denmark., Vergo S; Global Research, Novo Nordisk A/S, Maaloev, Denmark., Frederiksen KS; Global Research, Novo Nordisk A/S, Maaloev, Denmark., Haase C; Global Research, Novo Nordisk A/S, Maaloev, Denmark., Lundsgaard D; Global Research, Novo Nordisk A/S, Maaloev, Denmark.

Publikováno v: Gastroenterology research and practice [Gastroenterol Res Pract] 2018 Apr 10; Vol. 2018, pp. 5962624. Date of Electronic Publication: 2018 Apr 10 (Print Publication: 2018).